I'm just going to shift gears here a little bit. We've seen that there is a rationale for monitoring and evaluating real-world drug safety and effectiveness, and we've seen that that is compelling. Determining the best way to proceed is more complex. There are a variety of stakeholders, government health care professionals, patients, pharmaceuticals, researchers, and private insurers, and so on, with each stakeholder having a different perspective, but there could be common ground, and an integrated and comprehensive pharmaceutical surveillance system could be built.
In your opinion, is there a common understanding of the problem, and based on your analysis, what would be the best way to proceed in bringing everyone together?